1. Gotto A, Pownall H (2003) Manual of lipid disorders: reducing the risk for coronary heart disease. Lippincott, Williams and Wilkins, Philadelphia, PA
2. Alonzi T, Mancone C, Amicone L, Tripodi M (2008) Elucidation of lipoprotein particles structure by proteomic analysis. Expert Rev Proteomics 5:91–104
3. Trevaskis NL, Charman WN, Porter CJ (2008) Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 60:702–716
4. Wasan KM, Brocks DR, Lee SD, Sachs-Barrable K, Thornton SJ (2008) Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nat Rev Drug Discov 7:84–99
5. Danik M, Champagne D, Petit-Turcotte C, Beffert U, Poirier J (1999) Brain lipoprotein metabolism and its relation to neurodegenerative disease. Crit Rev Neurobiol 13:357–407